Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.

# Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake. **Read the full article:** [CNBC](https://www.cnbc.com/2026/03/31/eli-lilly-to-acquire-centessa-and-sleep-disorder-drugs.html) *This article was originally published by CNBC. MoneyWiseInc provides expert curation of the best financial content from trusted sources.*